Reducing chronic disease disparities in BIPOC communities in Minnesota
Center for Chronic Disease Reduction and Equity Promotion Across Minnesota (C2DREAM)
This study is working to help Black, Indigenous, and people of color in Minnesota live healthier lives by promoting better eating, more exercise, and quitting smoking, while also looking at how racism affects their health and finding ways to make things better together with the community.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project ID | NIH-10906139 on NIH RePORTER |
What this research studies
This research focuses on addressing the disparities in chronic diseases, particularly cardiovascular disease, affecting Black, Indigenous, and people of color (BIPOC) communities in Minnesota. It aims to implement community and primary care interventions that promote healthier diets, physical activity, and smoking cessation. By engaging with these communities, the project seeks to understand the impact of structural racism on health outcomes and develop tailored solutions to improve overall well-being. The approach includes innovative strategies that involve community participation and aim to create sustainable health equity.
Who could benefit from this research
Good fit: Ideal candidates for participation are adults from BIPOC communities in Minnesota who are at risk for or currently experiencing chronic diseases.
Not a fit: Patients who do not belong to BIPOC communities or those who do not have chronic disease risk factors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to significant improvements in health outcomes and reduced chronic disease rates among BIPOC populations.
How similar studies have performed: Previous research has shown success in community-based interventions targeting health disparities, indicating that this approach has potential for positive outcomes.
Where this research is happening
Minneapolis, United States
- University of Minnesota — Minneapolis, United States (Active)
Researchers
- Principal investigator: Allen, Michele L — University of Minnesota
- Study coordinator: Allen, Michele L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.